Market Currents
Bayer AG (BAYRY.PK) receives FDA approval for its Xarelto blood thinner treatment. The company...
-
Monday, November 7, 2011, 9:05 AM ETBayer AG (BAYRY.PK) receives FDA approval for its Xarelto blood thinner treatment. The company says a required warning that patients should consult their doctors if they want to stop taking the drug because of an increased risk of strokes "could be lifted" when a new study is completed. Shares up 2.8% in Frankfurt trading.
Other date
Latest Global Articles
